Sunniva (CSE: SNN) (OTCQX: SNNVF) was recently covered in a
publication by Beacon Securities Limited that argued that Sunniva is
significantly undervalued. An article further discussing the company reads:
“Cannabis supplier Sunniva Inc.’s (CSE: SNN) (OTCQX: SNNVF) strengthening
foothold in California’s and Canada’s consumer-populated markets has been
failing to translate to its stock price and market cap since it began trading
on the Canadian Securities Exchange and the U.S. OTCQX® Best Market in January,
leading investment researchers at Beacon Securities Limited (http://ibn.fm/K5a88) to classify
Sunniva’s public offering as a “badly mispriced” listing that could reward
investors who buy in at undervalued levels reported at the time of its July 30
market update, titled ‘Sunniva Inc. (CSE: SNN) California Dreams Have Never
Been This Cheap’. …Beacon Securities argues that Sunniva’s assets in
Canada are worth more than the company’s entire current $180 million market cap
and that its near-commercialization property in California is effectively being
given zero value, ‘or, in fact, negative — a proposition that is ludicrous
given the imminent launch of its 489,000 SF greenhouse (with on-site dispensary
and distribution license) in the world’s largest cannabis market in
California.’”
To view the full article, visit http://ibn.fm/TxRje
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically
integrated cannabis company operating in the world’s two largest cannabis
markets – Canada and California – where it is committed to delivering safe,
high-quality products and services at scale and creating trusted Sunniva
branded cannabis products. The company’s vision is to become one
of the lowest cost, highest quality vertically integrated cannabis
producers in the markets it serves by building large scale purpose-built
current cGMP designed greenhouses
and expansion of retail locations, offering better quality
assurance with cannabis products free from pesticides, providing
better customer access to cannabis education and sourcing better
therapeutic delivery devices. Sunniva’s management and board of
directors have a proven track record for creating significant shareholder value
both in the healthcare and biotech industries. For more information, visit the
company’s website at www.Sunniva.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
